Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4339 results

Sort By:

Essential Amino Acids and Parkinsons Disease

Study ID: NCT06604065
Start Date: 2026-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

AMS2434 (amino acids)

Placebo

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

Comparing Two Different Norepinephrine Infusion Rates for Prophylaxis Against Spinal-induced Hypotension in Elderly

Study ID: NCT07077265
Start Date: 2025-08
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

84

Intervention / Treatment

Norepinephrine (0.1 μg/kg/min)

Norepinephrine (0.07 μg/kg/min)

Sponsor

Kasr el Aini Hospital

Source: clinicaltrials.gov

Share:
Add to list

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

Study ID: NCT07034365
Start Date: 2025-08
End Date: 2027-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

No intervention

Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

Tele-Exercise for MERP

Study ID: NCT07018466
Start Date: 2025-12-01
End Date: 2030-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Tele-exercise

Standard of Care

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Study ID: NCT07023666
Start Date: 2025-09-30
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Deferoxamine

Deferasirox

Deferiprone

Echocardiography

Electrocardiogram (ECG)

Sponsor

Inova Health Care Services

Source: clinicaltrials.gov

Share:
Add to list

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

Study ID: NCT06525766
Start Date: 2025-10-15
End Date: 2030-10-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Biospecimen Collection

Bone Scan

Capecitabine

Computed Tomography

Magnetic Resonance Imaging

Administration questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

ELI in TBI 24 Hour

Study ID: NCT06701760
Start Date: 2026-01-05
End Date: 2031-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

264

Intervention / Treatment

Sodium Lactate

placebo

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list

A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population

Study ID: NCT06775665
Start Date: 2026-06-01
End Date: 2032-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment

No interventions were applied to the patients.

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Source: clinicaltrials.gov

Share:
Add to list

OM336 in Autoimmune Cytopenias

Study ID: NCT07083960
Start Date: 2025-08
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

donor

Sponsor

Gold Medicines

Source: clinicaltrials.gov

Share:
Add to list

A Trauma-Informed Intervention for the Newly HIV-Diagnosed

Study ID: NCT07055360
Start Date: 2026-01-05
End Date: 2026-09-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Resilience-Based Intervention for Stress Reduction and HIV-Related Efficacy (RISE)

Waitlist control: Text messaging-reminder comparison condition

Sponsor

Temple University

Source: clinicaltrials.gov

Share:
Add to list